moxifloxacin has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iannini, PB | 1 |
1 review(s) available for moxifloxacin and Metabolic Diseases
| Article | Year |
|---|---|
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Cardiovascular Diseases; Fluoroquinolones; Glucose; Homeostasis; Humans; Kidney Diseases; Liver Diseases; Metabolic Diseases; Moxifloxacin; Population Groups; Quinolines; Risk Factors | 2007 |